Donald Mcclain to Cyclophosphamide
This is a "connection" page, showing publications Donald Mcclain has written about Cyclophosphamide.
Connection Strength
0.038
-
Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G. Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Leuk Lymphoma. 2018 08; 59(8):1871-1877.
Score: 0.038